Vanda Pharmaceuticals (VNDA) FCF Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -3,042.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,042.00 |
| Dec 31, 2025 | -4,777.00 |
| Sep 30, 2025 | -2,556.00 |
| Jun 30, 2025 | -1,563.00 |
| Mar 31, 2025 | -8,304.00 |
| Dec 31, 2024 | 498.00 |
| Sep 30, 2024 | -2,559.00 |
| Jun 30, 2024 | 1,488.00 |
| Mar 31, 2024 | -3,487.00 |
| Dec 31, 2023 | -2,300.00 |
| Sep 30, 2023 | -2,477.00 |
| Jun 30, 2023 | -3,735.00 |
| Mar 31, 2023 | 4,421.00 |
| Dec 31, 2022 | -2,473.00 |
| Sep 30, 2022 | 601.00 |
| Jun 30, 2022 | -1,904.00 |
| Mar 31, 2022 | -786.00 |
| Dec 31, 2021 | 1,182.00 |
| Sep 30, 2021 | -172.00 |
| Jun 30, 2021 | -1,068.00 |
| Mar 31, 2021 | 1,667.00 |
| Dec 31, 2020 | 1,115.00 |
| Sep 30, 2020 | 555.00 |
| Jun 30, 2020 | 396.00 |
| Mar 31, 2020 | -2,159.00 |
| Dec 31, 2019 | -1,278.00 |
| Sep 30, 2019 | -783.00 |
| Jun 30, 2019 | 2,517.00 |
| Mar 31, 2019 | 1,594.00 |
| Dec 31, 2018 | 2,134.00 |
| Sep 30, 2018 | 1,307.00 |
| Jun 30, 2018 | 1,597.00 |
| Mar 31, 2018 | 1,904.00 |
| Dec 31, 2017 | 1,231.00 |
| Sep 30, 2017 | 268.00 |
| Jun 30, 2017 | 220.00 |
| Mar 31, 2017 | -87.00 |
| Dec 31, 2016 | -156.00 |
| Sep 30, 2016 | 2,187.00 |
| Jun 30, 2016 | -5,236.00 |
| Mar 31, 2016 | -3,627.00 |
| Dec 31, 2015 | 8,593.00 |
| Sep 30, 2015 | 3,157.00 |
| Jun 30, 2015 | 38,310.00 |
| Mar 31, 2015 | 28,447.00 |
| Dec 31, 2014 | 5,018.00 |
| Sep 30, 2014 | 6,625.00 |
| Jun 30, 2014 | -24,252.00 |
| Mar 31, 2014 | -14,954.00 |
| Dec 31, 2013 | 3,548.00 |
| Sep 30, 2013 | 482.00 |
| Jun 30, 2013 | 5,028.00 |
| Mar 31, 2013 | 1,602.00 |
| Dec 31, 2012 | -2,640.00 |
| Sep 30, 2012 | -3,244.00 |
| Jun 30, 2012 | -7,193.00 |
| Mar 31, 2012 | -8,589.00 |
| Dec 31, 2011 | -25,470.00 |
| Sep 30, 2011 | -2,038.00 |